Inhibition of tumour-induced angiogenesis by systemically administered protamine sulphate
Authors:
- 15 June 1984
- journal article
- experimetal cancer
- Published by Wiley in International Journal of Cancer
- Vol. 33 (6) , 831-833
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Protamine is an inhibitor of angiogenesisNature, 1982
- Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growthJournal of Cell Biology, 1981
- Mast cell heparin stimulates migration of capillary endothelial cells in vitro.Journal of Experimental Medicine, 1980
- Control of tumor growth in animals by infusion of an angiogenesis inhibitor.Proceedings of the National Academy of Sciences, 1980
- Inhibition of new blood vessel formation in mice by systemic administration of human rib cartilage extractCellular and Molecular Life Sciences, 1978
- Isolations of a Cartilage Factor That Inhibits Tumor NeovascularizationScience, 1976
- Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction.Journal of Experimental Medicine, 1975
- EFFECT OF PROTAMINE SULPHATE ON EXPERIMENTAL TUMOURS IN MICEThe Lancet, 1964
- TREATMENT OF MALIGNANT DISEASE WITH PROTAMINE SULPHATEThe Lancet, 1964
- PROTAMINE DERIVATIVES IN THE TREATMENT OF ADVANCED CARCINOMA OF THE BREASTThe Lancet, 1963